Company news
Pasithea Therapeutics Corp. news in 2023
Pasithea Therapeutics Corp.'s news releases, calls and decks from 2023, newest first.
Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023
December 27, 2023
Pasithea Therapeutics Announces Results from 2023 Annual Meeting
December 18, 2023
Pasithea Therapeutics Announces Positive In Vivo Preclinical Efficacy Data for PAS-004 from NRAS Mutation Cancer Xenograft Models
December 10, 2023
Pasithea Therapeutics Announces Outcome of Pre-IND Meeting with FDA for PAS-004 Clinical Development
November 28, 2023
Pasithea Therapeutics Announces Adjournment of 2023 Annual Meeting of Stockholders
November 28, 2023
Pasithea Therapeutics Selects PAS-003 Lead Development Candidate, a Humanized Monoclonal Antibody that Targets α5β1 Integrin for the Treatment of both Sporadic and Familial ALS
November 8, 2023
Pasithea Therapeutics Corp. Announces Final Results of Tender Offer
September 13, 2023
Pasithea Therapeutics to Participate in H.C. Wainwright 25th Annual Global Investment Conference
September 6, 2023
Pasithea Therapeutics publishes study in Proceedings of the National Academy of Sciences (PNAS) that shows an increase in α5 integrin expression in ALS human and mouse brain tissue, and further demonstrates targeting α5 integrin results in improved su...
July 31, 2023
Pasithea Therapeutics Special Committee Rejects Unsolicited Bid from Lucy Scientific Discovery, Inc.
July 19, 2023
Pasithea Therapeutics Announces Intention to Commence a $4.0 Million Tender Offer for its Common Stock at Price of $0.70 per Share in Cash
July 19, 2023
Pasithea Therapeutics Confirms Previous Creation of Independent Special Committee of its Board of Directors
June 29, 2023
Pasithea Therapeutics Announces Completion of GMP Manufacturing for PAS-004
June 28, 2023
Pasithea Therapeutics Confirms Receipt of Unsolicited Proposal from Lucy Scientific Discovery Inc.
June 5, 2023
Pasithea Therapeutics Abstract Accepted for Poster Presentation at 2023 Neurofibromatosis Conference
May 31, 2023
Pasithea Therapeutics to Participate in EF Hutton Inaugural Global Conference
May 2, 2023
Pasithea Therapeutics Chairman, Prof. Lawrence Steinman, to Deliver Keynote Address at the American Association for Advancement of Science (AAAS) Annual Meeting
March 1, 2023
Pasithea Therapeutics Chairman, Prof. Lawrence Steinman to Deliver Dr. Kenneth P. Johnson Lecture at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)
February 22, 2023
Pasithea Therapeutics Chairman, Prof. Lawrence Steinman to Receive Pioneer in Medicine Award
February 15, 2023
Pasithea Therapeutics Signs CMC Development and Manufacturing Agreement for the Production of PAS-004
January 17, 2023